Dermaheal Mesotherapy
Ingredient: 20mg/ml HA, PDRN, Various amino acid
Specification: 3ml,5ml
Package: Bottle
Application Area: Hydrating, anti-aging, stimulating collagen production, anti-oxidation, skin repair.
Product Introduction:
The hydrating benefits of Hyaluronic Acid extend to wound healing applications, where it helps to keep damaged skin moisturized and promotes faster tissue repair. Through powerful hydration and skin repair mechanisms, this product prevents dryness, restores radiance, and delays signs of aging while promoting collagen synthesis and protecting against oxidative stress.
Product Display:
Product Details:
Type | PDRN Skin Booster |
Specification | 2.5ml, 5ml |
Application area | Facial dermal mesoderm |
Product efficacy | Anti-aging, stimulating collagen production, anti-oxidation, skin repaire |
How to choose | According to the customer's skin type, age and customer needs to choose |
Package | Bottle |
Storage | Room temperature (1-25ºC), cool and dry place |
Recommended | 1-2 pc |
Recommended interval | 1 month |
Lasting time | 1 month |
Heavy metal residue | ≤10μg/g |
Endotoxin content | <0.5EU/mL |
Product Package:
Customer Feedback:
Raw Material Advantages:
1. Hyaluronic Acid injections provide immediate and natural-looking results in aesthetic procedures, enhancing facial volume while maintaining a soft and flexible texture.
2. When applied to the skin, Hyaluronic Acid enhances the penetration of other skincare ingredients, allowing actives like Vitamin C and niacinamide to work more effectively.
3. The presence of Hyaluronic Acid in skincare products helps to reinforce the skin’s natural moisture barrier, preventing dehydration caused by environmental factors such as wind and pollution.
Development Process:
Company Introduction:
The R&D platform features a team of 30 specialists managing a 1,426m² sub-platform for major drug development in Shandong, offering a 10,000-class clean pilot workshop, sterility and microbiology labs, physicochemical testing, and advanced water purification, providing ideal conditions for Class III medical device R&D and approval. Our medical material industrialization platform integrates cutting-edge sterile dispersion techniques for non-homogeneous high-viscosity polymer implants, innovative stable suspension methods, advanced gel granulation research, and state-of-the-art aseptic processing and packaging for bioactive materials.